BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2 AND Staging
1653 results:

  • 1. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
    Sorokin P; Novozhilov M; Utkin D; Abduragimova Z; Dudina I; Nikiforchin A; Kulikova S
    Klin Onkol; 2024; 38(2):126-133. PubMed ID: 38697821
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
    Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
    Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 5. Squamous cell carcinoma malignant transformation in mature cystic teratoma of the ovary: a case report and review of the literature.
    Jafari-Nozad AM; Jahani N; Nazeri N
    J Med Case Rep; 2024 Mar; 18(1):145. PubMed ID: 38523295
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
    Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
    Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
    Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
    Li N; Chen Q; Li B
    Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses.
    Sköld C; Jansson AK; Glimelius I
    J Intern Med; 2024 Jun; 295(6):715-734. PubMed ID: 38468475
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Discrepancies in staging and perioperative classification of pelvic endometriosis according to #Enzian 2021.
    Križanová K; Chvátal R; Križan V; Shibaeva M; Hudeček R
    Ceska Gynekol; 2024; 89(1):16-21. PubMed ID: 38418248
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Role of Lymphovascular Space Invasion and Cytology in the Prognosis of Endometrial cancer.
    Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
    Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
    Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
    World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The significance of lower uterine segment involvement in endometrial cancer.
    Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
    Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
    Jassar A; Hemali N; Bhatnagar A
    Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
    Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
    Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
    Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
    Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
    Khessib T; Jha P; Davidzon GA; Iagaru A; Shah J
    Semin Nucl Med; 2024 Mar; 54(2):270-292. PubMed ID: 38342655
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
    Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
    Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Counselling Framework for Germline
    Wong SM; Apostolova C; Eisenberg E; Foulkes WD
    Curr Oncol; 2024 Jan; 31(1):350-365. PubMed ID: 38248108
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 83.